Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study

L Saltz; S Clarke; E Diaz-Rubino; W Scheithauer; A Figer; R Wong; S Koski; M Lichinitser; T-S Yang; F Rivera; F Sirzen; J Cassidy; Pirkko-Liisa Kellokumpu-Lehtinen

doi:10.1200/jco.2007.14.9930

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study

L Saltz, S Clarke, E Diaz-Rubino, W Scheithauer, A Figer, R Wong, S Koski, M Lichinitser, T-S Yang, F Rivera, F Sirzen, J Cassidy, Pirkko-Liisa Kellokumpu-Lehtinen

Department of Oncology

Research output: Contribution to journal › Article › Scientific › peer-review

2337 Citations (Scopus)

Original language	English
Pages (from-to)	2013-2019
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	26
Issue number	12
DOIs	https://doi.org/10.1200/jco.2007.14.9930
Publication status	Published - 2008
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2007.14.9930

Cite this

Saltz, L., Clarke, S., Diaz-Rubino, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T-S., Rivera, F., Sirzen, F., Cassidy, J., & Kellokumpu-Lehtinen, P-L. (2008). Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study. JOURNAL OF CLINICAL ONCOLOGY, 26(12), 2013-2019. https://doi.org/10.1200/jco.2007.14.9930

@article{e564433905624086a514cb4f6e80f223,

title = "Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study",

author = "L Saltz and S Clarke and E Diaz-Rubino and W Scheithauer and A Figer and R Wong and S Koski and M Lichinitser and T-S Yang and F Rivera and F Sirzen and J Cassidy and Pirkko-Liisa Kellokumpu-Lehtinen",

year = "2008",

doi = "10.1200/jco.2007.14.9930",

language = "English",

volume = "26",

pages = "2013--2019",

journal = "JOURNAL OF CLINICAL ONCOLOGY",

issn = "0732-183X",

number = "12",

}

Saltz, L, Clarke, S, Diaz-Rubino, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Lichinitser, M, Yang, T-S, Rivera, F, Sirzen, F, Cassidy, J & Kellokumpu-Lehtinen, P-L 2008, 'Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study', JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 12, pp. 2013-2019. https://doi.org/10.1200/jco.2007.14.9930

TY - JOUR

T1 - Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic coloractal cancer: A randomized phase III study

AU - Saltz, L

AU - Clarke, S

AU - Diaz-Rubino, E

AU - Scheithauer, W

AU - Figer, A

AU - Wong, R

AU - Koski, S

AU - Lichinitser, M

AU - Yang, T-S

AU - Rivera, F

AU - Sirzen, F

AU - Cassidy, J

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

PY - 2008

Y1 - 2008

U2 - 10.1200/jco.2007.14.9930

DO - 10.1200/jco.2007.14.9930

M3 - Article

SN - 0732-183X

VL - 26

SP - 2013

EP - 2019

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 12

ER -